UnknownPHASE1, PHASE2NCT02917681

Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Sao Paulo General Hospital
Principal Investigator
Gerson Chadi, MD, PhD
Full Professor
Intervention
Two intrathecal MSC injections(other)
Enrollment
28 enrolled
Eligibility
18-70 years · All sexes
Timeline
20162019

Study locations (1)

Collaborators

Pontifícia Universidade Católica do Paraná

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02917681 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials